InnovAge (OTCMKTS:INNV) Share Price Passes Above 50 Day Moving Average of $5.17

Shares of InnovAge Holding Corp. (OTCMKTS:INNVGet Free Report) crossed above its 50-day moving average during trading on Thursday . The stock has a 50-day moving average of $5.17 and traded as high as $6.30. InnovAge shares last traded at $6.03, with a volume of 42,786 shares traded.

InnovAge Trading Up 1.0 %

The firm has a market capitalization of $828.17 million, a PE ratio of -25.38 and a beta of 0.39. The business has a 50 day moving average price of $5.21 and a 200-day moving average price of $4.88. The company has a current ratio of 1.57, a quick ratio of 1.57 and a debt-to-equity ratio of 0.25.

InnovAge (OTCMKTS:INNVGet Free Report) last issued its earnings results on Tuesday, May 7th. The company reported ($0.04) earnings per share (EPS) for the quarter, hitting analysts’ consensus estimates of ($0.04). The business had revenue of $193.07 million during the quarter, compared to the consensus estimate of $188.64 million. InnovAge had a negative return on equity of 13.04% and a negative net margin of 6.17%. Analysts expect that InnovAge Holding Corp. will post -0.25 earnings per share for the current year.

InnovAge Company Profile

(Get Free Report)

InnovAge Holding Corp. manages and provides a range of medical and ancillary services for seniors in need of care and support to live independently in their homes and communities. The company manages its business through Program of All-Inclusive Care for the Elderly (PACE) approach. It also offers in-home care services consisting of skilled, unskilled, and personal care; in-center services, such as primary care, physical therapy, occupational therapy, speech therapy, dental services, mental health and psychiatric services, meals, and activities; transportation to the PACE center and third-party medical appointments; and care management.

See Also

Receive News & Ratings for InnovAge Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for InnovAge and related companies with MarketBeat.com's FREE daily email newsletter.